Literature DB >> 3396403

Bronchoalveolar lavage in the normal volunteer subject. I. Technical aspects and intersubject variability.

D B Ettensohn1, M J Jankowski, P G Duncan, P A Lalor.   

Abstract

To investigate subject-to-subject variability in commonly used parameters from bronchoalveolar lavage (BAL), we analyzed the results of BAL from 78 consecutive normal volunteer subjects. The BAL was performed using three, 40 ml aliquots of normal saline solution, in a lingular subsegment. The same diameter bronchoscope (4.8 mm) was used and BAL was performed and analyzed identically in all subjects. While the percentage of lavageate returned was relatively consistent from subject to subject (63.4 +/- 10.8 percent, mean +/- SD), there was marked variability in the number of cells obtained (7.3 +/- 3.9 X 10(6)). While low returns were generally associated with a diminished cell recovery, in the range of normal percentage returned, there was no correlation with the number recovered. There was no correlation of cell number or percent lavageate returned with gender, height, or any lung volume (as determined on pulmonary function tests). There was relatively little variability in differential analysis of recovered cells. The BAL was well tolerated by all subjects; the chest roentgenogram was found to be of little utility in screening normal subjects, but pulmonary function testing detected obstructive lung disease in three potential subjects leading to their disqualification as "normal." Our experience confirms the safety of bronchoalveolar lavage in normal volunteer subjects. We report the BAL results that can be expected for research or clinical comparison using a protocol described in detail. The variability of cell numbers from BAL, even under these controlled conditions, precludes the routine use of this measurement from BAL performed for clinical purposes.

Entities:  

Mesh:

Year:  1988        PMID: 3396403     DOI: 10.1378/chest.94.2.275

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  15 in total

1.  Single-dose intrapulmonary pharmacokinetics of rifapentine in normal subjects.

Authors:  J E Conte; J A Golden; M McQuitty; J Kipps; E T Lin; E Zurlinden
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

2.  Temperature and serum proinflammatory cytokine changes in patients with NSCLC after BAL.

Authors:  G Georgiades; P Myrianthefs; K Venetsanou; A Kythreoti; A Kyroudi; C Kittas; G Baltopoulos
Journal:  Lung       Date:  2003       Impact factor: 2.584

3.  Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.

Authors:  Stephan Schwander; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2010-11-12       Impact factor: 21.405

4.  Prophylactic sequential bronchoscopy after inhalation injury: results from a three-year prospective randomized trial.

Authors:  J A Carr; N Crowley
Journal:  Eur J Trauma Emerg Surg       Date:  2013-01-22       Impact factor: 3.693

5.  The acute pulmonary inflammatory response to the graded severity of smoke inhalation injury.

Authors:  Joslyn M Albright; Christopher S Davis; Melanie D Bird; Luis Ramirez; Hajwa Kim; Ellen L Burnham; Richard L Gamelli; Elizabeth J Kovacs
Journal:  Crit Care Med       Date:  2012-04       Impact factor: 7.598

6.  Glucose stimulates phagocytosis of unopsonized Pseudomonas aeruginosa by cultivated human alveolar macrophages.

Authors:  S Y Wong; L M Guerdoud; A Cantin; D P Speert
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

7.  Ubiquitin and stromal cell-derived factor-1α in bronchoalveolar lavage fluid after burn and inhalation injury.

Authors:  Todd A Baker; Christopher S Davis; Harold H Bach; Jacqueline Romero; Ellen L Burnham; Elizabeth J Kovacs; Richard L Gamelli; Matthias Majetschak
Journal:  J Burn Care Res       Date:  2012 Jan-Feb       Impact factor: 1.845

8.  Comparison of two aspiration techniques of bronchoalveolar lavage in children.

Authors:  Christian Rosas-Salazar; Stephen A Walczak; Daniel G Winger; Geoffrey Kurland; Jonathan E Spahr
Journal:  Pediatr Pulmonol       Date:  2013-10-24

9.  Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin.

Authors:  J E Conte; J A Golden; S Duncan; E McKenna; E Zurlinden
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

10.  Proteasomes in human bronchoalveolar lavage fluid after burn and inhalation injury.

Authors:  Joslyn M Albright; Jacqueline Romero; Vikas Saini; Stephan U Sixt; Melanie D Bird; Elizabeth J Kovacs; Richard L Gamelli; Jürgen Peters; Matthias Majetschak
Journal:  J Burn Care Res       Date:  2009 Nov-Dec       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.